BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA Says Johnson & Johnson (JNJ)'s TB Drug Appears Safe


11/26/2012 1:10:30 PM

The Food and Drug Administration said a proposed experimental drug being developed by a unit of Johnson & Johnson JNJ -0.93% to treat a drug-resistant form of tuberculosis appeared "safe and well-tolerated." J&J is seeking approval of a drug called bedaquiline as a tuberculosis treatment. The company is seeking what is called accelerated approval of bedaquiline, which is a type of temporary approval based on less clinical data than required for regular approval. The product will be reviewed Wednesday by the FDA's anti-infective drugs advisory committee, which is made up of non-FDA medical experts. The agency released a review of the product Monday in advance of the meeting. Tuberculosis is a bacterial infection that mostly involves the lungs. It is treated with a combination of four drugs for at least six months, according to the National Heart, Lung, and Blood Institute. However, there is evidence that some forms of TB can't be treated with currently available drugs, which the FDA said "threatens to erode the progress made in the world-wide control of tuberculosis." Bedaquiline is designed to work in a new way to treat TB and would be used with other drugs.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES